Jamjoom Pharmaceuticals Factory Company SJSC
SAU:4015
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
105.6
157.4
|
Price Target |
|
We'll email you a reminder when the closing price reaches SAR.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one Jamjoom Pharmaceuticals Factory Company SJSC stock under the Base Case scenario is 102.3 SAR. Compared to the current market price of 156 SAR, Jamjoom Pharmaceuticals Factory Company SJSC is Overvalued by 34%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Jamjoom Pharmaceuticals Factory Company SJSC
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for Jamjoom Pharmaceuticals Factory Company SJSC cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
Jamjoom Pharmaceuticals Factory Company SJSC
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Jamjoom Pharmaceuticals Factory Company SJSC
Balance Sheet Decomposition
Jamjoom Pharmaceuticals Factory Company SJSC
Current Assets | 1.1B |
Cash & Short-Term Investments | 161.3m |
Receivables | 628.9m |
Other Current Assets | 292.3m |
Non-Current Assets | 732.2m |
Long-Term Investments | 42.9m |
PP&E | 677.1m |
Intangibles | 12.1m |
Other Non-Current Assets | 10 |
Current Liabilities | 274.6m |
Accounts Payable | 258.2m |
Other Current Liabilities | 16.4m |
Non-Current Liabilities | 76.8m |
Long-Term Debt | 1.9m |
Other Non-Current Liabilities | 75m |
Earnings Waterfall
Jamjoom Pharmaceuticals Factory Company SJSC
Revenue
|
1.2B
SAR
|
Cost of Revenue
|
-458m
SAR
|
Gross Profit
|
773.7m
SAR
|
Operating Expenses
|
-415.9m
SAR
|
Operating Income
|
357.8m
SAR
|
Other Expenses
|
-26.1m
SAR
|
Net Income
|
331.7m
SAR
|
Free Cash Flow Analysis
Jamjoom Pharmaceuticals Factory Company SJSC
SAR | |
Free Cash Flow | SAR |
Profitability Score
Profitability Due Diligence
Jamjoom Pharmaceuticals Factory Company SJSC's profitability score is 67/100. The higher the profitability score, the more profitable the company is.
Score
Jamjoom Pharmaceuticals Factory Company SJSC's profitability score is 67/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Jamjoom Pharmaceuticals Factory Company SJSC's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Score
Jamjoom Pharmaceuticals Factory Company SJSC's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Jamjoom Pharmaceuticals Factory Company SJSC
According to Wall Street analysts, the average 1-year price target for Jamjoom Pharmaceuticals Factory Company SJSC is 173.99 SAR with a low forecast of 165.39 SAR and a high forecast of 184.8 SAR.
Dividends
Current shareholder yield for Jamjoom Pharmaceuticals Factory Company SJSC is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Jamjoom Pharma is pharmaceutical company. The firm operates two segments, which include pharmaceutical products, that represents medicines or drugs, which all are essential for the prevention and treatment of diseases, and protection of public health; and Consumer health products segment that represents the products sold directly to consumers. The Company’s subsidiaries include Al Jamjoom Pharma for Pharmaceutical Industries and Jamjoom Pharmaceutical Industry and Commerce Company Limited and the Company also operates approximately 8 branches.
Contact
IPO
Employees
Officers
The intrinsic value of one Jamjoom Pharmaceuticals Factory Company SJSC stock under the Base Case scenario is 102.3 SAR.
Compared to the current market price of 156 SAR, Jamjoom Pharmaceuticals Factory Company SJSC is Overvalued by 34%.